Search

Tacaciclib

Tacaciclib has a monoisotopic molecular weight of 528.28 Da. … Tacaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Tacaciclib is a cyclin dependant kinase inhibitor.

Fovinaciclib

Fovinaciclib has a monoisotopic molecular weight of 548.3 Da. … Fovinaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor.

Zeprumetostat

Zeprumetostat is a small molecule drug. The usage of the INN stem '-metostat' in the name indicates that Zeprumetostat is a histone N-methyltransferase inhibitor. … Zeprumetostat has a monoisotopic molecular weight of 548.34 Da.

DP-VPA

DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

Darapladib

GR270773

infusion between healthy adults and those with damaged livers) and NCT00089986 (completed with results, treatment of suspected or confirmed gram-negative severe sepsis in adults, comparing GR270773 with a

AMP-201

AMP-201 comprises an adeno-associated virus type 8 vector (AAV8) encoding the collagen Q gene (COLQ). It is under investigation for the treatment of collagen Q congenital myasthenia.

Minzasolmin

Minzasolmin is under investigation in clinical trial NCT05543252 (An Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Study Participants With Parkinson's

NRP369

NRP369 is an oxycodone derivative under investigation for the treatment of pain (moderate to moderately severe). NRP369 was developed by New River Pharmaceuticals as a backup therapeutic to [NRP290].

9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide

9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide is an inactive derivative of the antitumour agents N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and 9-amino-DACA.